Halozyme Therapeutics | HALO - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Acadia Pharmaceuticals USD 44.57M 32.32M 2026-06
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Amarin USD 18.8M 29.36M 2026-06
Amgen USD 2.86B 16.65B 2026-06
Baxter International USD 1.03B 52M 2026-06
Cara Therapeutics USD 4.62M 1.4M 2026-03
Cytokinetics USD 20.51M 4.2M 2026-06
DBV Technologies USD 39.5M 1.44M 2026-03
Eli Lilly USD 6.11B 1.08B 2026-06
Halozyme Therapeutics USD 23.61M 9.51M 2026-06
Intrexon USD 4.85M 3.12M 2024-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
MannKind USD 11.04M 5.1M 2026-06
Minerva Neurosciences USD 640K 305K 2025-12
Nektar Therapeutics USD 10.03M 744K 2026-03
Pfizer USD 4.58B 75M 2026-06
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
United Therapeutics USD 497.8M 500K 2026-06
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12